Global In Vivo CRO Market is anticipated
to grow at a higher CAGR in the forthcoming period. Driving factors responsible
for the growth of In Vivo Contract Research Organization (CRO) Market includes
technological developments in medical science. Web-based life science labs and robotics
used for conducting contribute to the growth of the market. Other factors such
as rise in R&D for cancer, aging, HIV/AIDS immunology, drug addiction,
alcoholism, diabetes and behavioral sciences propel the demand for in Vivo CRO
industry.
Browse Details of In
Vivo CRO Market at:
https://www.millioninsights.com/industry-reports/in-vivo-contract-research-organization-cro-market
https://www.millioninsights.com/industry-reports/in-vivo-contract-research-organization-cro-market
In Vivo CROs provide outsourced
research services to biotechnology and medical device industries enabling them
to deal with R&D costs effectively by allowing them to focus on core
competencies. Services include drug & device research and development,
comprising drug discovery, preclinical and clinical trials, data management,
post-marketing surveillance and consulting.
Based on segmentation by type, In
Vivo CRO industry includes rodent and non-rodent. Based on segmentation by
application, In Vivo CRO industry includes clinics and hospitals. Rodent type
dominates the market growth owing to predominance usage for preclinical
evaluation. Mice and rats possess a chromosomal form identical to humans which
again stimulates the growth of rodent segment.
Based on segmentation by type of
diseases, In Vivo CRO market includes autoimmune/inflammation conditions, pain
management, CNS conditions, oncology, diabetes and obesity. Oncology dominates
the market growth owing to rise in cancer cases worldwide and increasing focus
by pharmaceutical companies on manufacturing innovative and novel drug
conditions with fewer side-effects.
Geographically, In Vivo CRO
industry spans North America, South America, Europe, Middle-East, Asia-Pacific
and Africa. North America held a substantial share in the market growth owing
to presence of advanced CRO in this region. APAC market is expected to witness
a lucrative growth in the forecast period owing to untapped favorable
opportunities, presence of consumer base and rapid economic development. The
key players in in vivo CRO market include Quintiles, Charles River
Laboratories, ICON Plc, Covance Inc, Parexel International, Theorem Clinical
Research, inVentive Health, WuXi App Tec Inc., American Preclinical Services
LLC, Evotec Inc and Pharmaceutical Product Development LLC.
Request Free Sample
Copy of In Vivo CRO Market at:
https://www.millioninsights.com/industry-reports/in-vivo-contract-research-organization-cro-market/request-sample
https://www.millioninsights.com/industry-reports/in-vivo-contract-research-organization-cro-market/request-sample
No comments:
Post a Comment